NEW YORK, Aug. 22nd, 2022/PRNewswire”The “Sciatica treatment market by type and Geography (Sciatica Treatment Market by Type and Geographical Area) Forecast and Analysis 2022-2026” report is now part of Technavio’s product line. The growth potential difference between this sciatica treatment market in 2021-2026 ranges from USD 2.52 billion. To find out the exact CAGR as well as the year-over-year growth rate, request the PDF sample report for FREE.
Key Market Dynamics
- Market Factor Market Driver growing awareness about sciatica is fueling the growth of sciatica therapy market. Awareness of sciatica is rising due to efforts made by the government as well as non-governmental organizations. For example, HCA Healthcare UK educates individuals on symptoms screening, diagnosis and symptoms, and possible treatments to treat sciatica throughout the UK. In the same way, myDr.com.au, an Australian healthcare site, provides pertinent details on various health issues. Additionally, OrthoInfo, the American Academy of Orthopaedic Surgeons (AAOS) patient education site promotes awareness about sciatica via videos, articles and animations, both across the US.
- Market Problem Market Challenge: The inability to approve treatments could hinder market participants in the sciatica treatment market over the forecast time. Patients suffering from sciatica suffer from pain along the pathway that runs through their sciatic nerve. But, there isn’t any prescribed treatment approved for sciatica. The use of NSAIDs or analgesics are able to treat just the symptoms of the disease. Additionally epidural injections of corticosteroids or physiotherapy as well as bracing can be considered to treat symptoms. Surgery is only recommended in cases where non-surgical treatment fails. Thus, the absence of approved treatment options for sciatica is likely to hinder the development of the world sciatica therapy market.
Technavio provides major drivers, trends and challenges that will shape how we approach technology and the sciatica treatments market. Purchase now to gain access to this data
Market Segmentation
Based on kind By type, by type, the surgical impact segment will experience the most market share during the forecast time. Non-surgical treatment options for sciatica include epidural nonsteroidal anti-inflammatory medications (NSAIDs) corticosteroid injections, narcotics tricyclic antidepressants such as anti-seizure medicines, as well as physical treatments. The availability of epidural corticosteroid injections off-label is driving the expansion of this area. Corticosteroids are the most effective treatment for treating inflammation that is caused by sciatica.
North America is expected to be the most dominant region, accounting for 37 percent of the market’s expansion in the forecast period. In the US along with Canada have been identified as major players in this sciatica treatment market within the region. The rapid growth in this region is due to factors like rising awareness of the condition and strategic alliances between suppliers. But, the growth of markets in this area will be slower than the markets across other areas.
Check out our free Sample PDF report for a deeper understanding of the contributions of all segments and opportunities for regional markets included in our sciatica treatments market research report.
Certain companies mentioned
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Bayer AG
- Dr. Reddys Laboratories Ltd.
- Fresenius SE and Co. KGaA
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals Plc
- Johnson and Johnson
- Lupin Ltd.
- Nidd Valley Medical
- Novartis AG
- Omega Laser Systems Ltd.
- Ozone Pharmaceuticals Ltd.
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Want your report customized? Talk to an analyst and customize your report to your specifications.
Similar Reports
Celiac Diseases Market for Drugs according to the Therapy type and Geography Forecast and Analyse 2022-2026
Polycystic Kidney Disease Drugs Markets by type and Geography Forecast and analysis 2022-2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Explore Market Reports on Health Market Reports
Important Topics covered
1 Executive Summary
- 1.1 Market overview
- Exhibit 1: Executive Summary Chart of Market Overview
- Exhibit 2: Executive Summary Summary of Market Data
- Exhibit 3: Executive Summary Chart of the Global Market Specifications
- Exhibit 04 Executive Summary Chart of the Market by Geography
- Exhibit 5: Executive Summary Chart of Market Segmentation by Type
- Exhibit 06: Executive Summary Diagram of growth in increments
- Exhibit 07: Executive Summary Data Table on Growth Rates
- Exhibit 8: Executive Summary Chart of the Vendor’s Market Positioning
2. Market Landscape
- 2.1 Market ecosystem
- Exhibit 09 Market parent
- Exhibit 10 Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: The offerings from vendors that are that are included in the definition of market
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Size of the market in 2021
- 3.4 Market outlook 2021-2026 forecast
- Illustration 13: Chart showing Global market size and the forecast 2021-2026 ($ million)
- Exhibit 14 Information Table for Global Size of the market and projection 2021-2026 ($ million)
- Figure 15: Table of Global Market: Year-over-year growth 2021-2026 ( percent)
- Exhibit 16 The Data Table of Global Market: Year-over-year growth 2021-2026 ( percent)
4. Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Analysis of Five Forces A comparison Between 2021 and 2026
- 4.2 Buyers’ bargaining power
- Illustration 18: Diagram showing Buyers’ bargaining power the impact of major factors 2021 and 2026
- 4.3 Bargaining the power of suppliers
- Exhibit 19: The power of bargaining of suppliers – The impact of the key elements in 2021 and 2026.
- 4.4 Risk of new entrants
- Exhibit 20: The threat of new entrants and the impact of major factors in 2021 and 2026.
- 4.5 Risk of substitution
- Exhibit 21: Threats of substitutes – Effect of important elements in 2021 and 2026.
- 4.6 Threat of competition
- Exhibit 22: The threat of rivalry – Impact the most important elements on 2021 and 2026
- 4.7 Market conditions
- Illustration 23: Chart showing market condition 5 factors 2021 and 2026
5 Market Segmentation according to Type
- 5.1 Market segments
- Illustration 24: Diagram of Type 2021-2026 market share ( percent)
- Exhibit 25: Table of Data on Type Market Share 2021-2026 ( percent)
- 5.2 Comparative Analysis by Type
- Tableau 26 Exhibit of Comparison based on Type
- Exhibit 27: Table of Data for Comparison based on Type
- 5.3 Non-surgical treatments Market size and outlook 2021-2026
- Illustration 28: Diagram of Non-surgical treatments – Market size and outlook 2021-2026 ($ million)
- Exhibit 29 The Data Table of Non-Surgical Treatment Size and outlook 2021-2026 ($ million)
- Figure 30: Table of Non-surgical treatment growth year-over-year 2021-2026 ( percent)
- Exhibit 31: Table of Data on non-surgical treatment – Year-over year growth between 2021 and 2026 ( percent)
- 5.4 Surgery – Market size and outlook 2021-2026
- Figure 32: Table for The market for surgical treatment and projection 2021-26 (millions of dollars)
- Exhibit 33: Table of Data on Surgical treatment Size and outlook 2021-2026 ($ million)
- Table 34 of the growth of surgical treatment over time – Year-over-year 2021-2026 ( percent)
- Exhibit 35: Table of Data on Surgical Treatment – Year-over-year growth from 2021 to 2026 (%))
- 5.5 Market opportunity based on the type
- Exhibit 36: Opportunity in the market through Type (Million dollars)
6 Landscape of the Customer
- 6.1 Customer landscape overview
- Exhibit 37 Analyzing price response, lifecycle, baskets of purchases by customers and adoption rates. buying selection criteria
7 Geographical Landscape
- 7.1 Geographic segmentation
- Figure 38: Table of market share by geography 2021-2026 ( percent)
- Exhibit 39 The Data Table of Market Share by region 2021-2026 (%))
- 7.2 Comparative geography
- Exhibit 40: Chart of Geographic comparison
- Exhibit 41 Data Table on Geographical Comparison
- 7.3 North America Market size and the forecast for 2021-2026
- Illustration 42: Chart of North America – Size of the market and projection 2021-2026 ($ million)
- Exhibit 43: Table of Data about North America – Size of the market and outlook 2021-2026 ($ million)
- Figure 44: Table of North America – Growth year-over-year 2021-2026 ( percent)
- Exhibit 45: Table of Data about North America – Growth year-over-year 2021-2026 ( percent)
- 7.4 Europe – Market size and projection 2021-2026
- Table showing Europe market size and outlook 2021-2026 ($ million)
- Exhibit 47 The Data Table of Europe Size of the market and projection 2021-2026 ($ million)
- Exhibit 48: Diagram on Europe year-over-year growth from 2021 to 2026 ( percent)
- Exhibit 49 Information Table for Europe year-over-year growth between 2021 and 2026 ( percent)
- 7.5 Asia – Market size and projection 2021-2026
- Figure 50: Chart of Asia Market size and outlook 2021-2026 ($ million)
- Exhibit 51 Information Table for Asia Size of the market and outlook 2021-2026 ($ million)
- Figure 52: Table of Asia year-over-year growth between 2021-2026 ( percent)
- Exhibit 53 Information Table for Asia Year-over-year growth from 2021 to 2026 ( percent)
- 7.6 7.6 of World (ROW) – Market size and projection 2021-2026
- Illustration 54: Chart of Rest of World (ROW) Forecast and size of the market 2021-26 (millions of dollars)
- Exhibit 55: Table of Data on the Rest of World (ROW) – Size of the market and the forecast for 2021-2026 ($ million)
- Exhibit 56: Diagram on the Rest of World (ROW) – Growth year-over-year 2021-2026 ( percent)
- Exhibit 57: Table of Data of Rest of World (ROW) Growth of 2021-2026 ( percent)
- 7.7 US – Market size and the forecast for 2021-2026
- Figure 58: Table showing US market size and the forecast 2021 to 2026 (Million dollars)
- Exhibit 59: Table of Data on US market size and projection 2021-2026 ($ million)
- Exhibit 60: Chart of US Year-over-year growth between 2021 and 2026 ( percent)
- Exhibit 61: Table of Data on US year-over-year growth between 2021 and 2026 ( percent)
- 7.8 Canada – Market size and the forecast for 2021-2026
- Illustration 62: Table showing Canada Market size and projected 2021-2026 ($ million)
- Exhibit 63: Table of Data about Canada Size of the market and outlook 2021-2026 ($ million)
- Exhibit 64: Chart of Canada Year-over-year growth between 2021-2026 ( percent)
- Exhibit 65: Table of Data about Canada year-over-year growth between 2021 and 2026 ( percent)
- 7.9 UK – Market size and the forecast for 2021-2026
- Figure 66: Chart of UK market size and its forecast 2021-2026 ($ million)
- Exhibit 67: Table of Data on UK market size and outlook 2021-2026 ($ million)
- Illustration 68: Chart of UK Growth 2021-2026 ( percent)
- Exhibit 69: Table of Data on UK Growth 2021-2026 ( percent)
- 7.10 Germany – Market size and projection 2021-2026
- Illustration 70: Diagram showing Germany market size and projection 2021-26 (Million dollars)
- Exhibit 71: Table of Data for Germany Size of the market and projection 2021-2026 ($ million)
- Exhibit 72: Diagram on Germany year-over-year growth between 2021 and 2026 ( percent)
- Exhibit 73: Table of Data for Germany year-over-year growth between 2021 and 2026 ( percent)
- 7.11 China – Market size and projection 2021-2026
- Diagram showing China market size and outlook 2021-26 (Million dollars)
- Exhibit 75: Table of Data about China market size and outlook 2021-2026 ($ million)
- Exhibit 76: Diagram on China Year-over-year growth between 2021 and 2026 ( percent)
- Exhibit 77: Table of Data about China year-over-year growth between 2021 and 2026 ( percent)
- 7.12 Australia – Market size and the forecast for 2021-2026
- Diagram of Australia Size of the market and outlook 2021-2026 ($ million)
- Exhibit 79: Table of Data about Australia Size of the market and outlook 2021-2026 ($ million)
- Exhibit 80: Diagram on Australia year-over-year growth from 2021 to 2026 ( percent)
- Exhibit 81: Table of Data about Australia Year-over-year growth between 2021 and 2026 ( percent)
- 7.13 Opportunities for market entry based on location
- Exhibit 82: Opportunities in the market according to geography (millions of dollars)
8: Drivers, Issues and Trends
- 8.1 Market drivers
- 8.2 Market problems
- 8.3 Impact of challenges and drivers
- Exhibit 83: The impact of drivers and challenges 2021 and 2026.
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview of the importance of inputs and factors of differentiating
- 9.3 Landscape disruption
- Exhibit 85: A brief overview of aspects of disruption
- 9.4 Risks in the industry
- Exhibit 86: Effects of major risks on the business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Positioning of vendors in the market
- Exhibit 88: Matrix for vendor positions and classification
- 10.3 Apotex Inc.
- Exhibit 89 Apotex Inc. – Overview
- Exhibit 90 Apotex Inc. – Service / Product
- Exhibit 91 Apotex Inc. – The most important products
- 10.4 Bayer AG
- Exhibit 92 Bayer AG – Overview
- Exhibit 93: Bayer AG – Business segments
- Exhibit 94 Bayer AG – Key products
- Exhibit 95: Bayer AG – Segment focus
- 10.5 Fresenius SE and Co. KGaA
- Exhibit No. 96: Fresenius SE Company. KGaA – Overview
- Exhibit97 Fresenius, SE and Company. KGaA – Business segments
- Exhibit 99: Fresenius Se and Co. the KGaA. Key developments
- Exhibit 99 Fresenius SE and Company. KGaA – Key offerings
- Exhibit 100 Fresenius SE and Company. KGaA – Segment focus
- 10.6 Glenmark Pharmaceuticals Ltd.
- Exhibit 101: Glenmark Pharmaceuticals Ltd. – Overview
- Exhibit 102: Glenmark Pharmaceuticals Ltd. – Product / Service
- Exhibit No. 103 Glenmark Pharmaceuticals Ltd. The key products
- 10.7 Hikma Pharmaceuticals Plc
- Exhibit 104: Hikma Pharmaceuticals Plc – Overview
- Exhibit 105: Hikma Pharmaceuticals Plc – Business segments
- Exhibit 106:Hikma Pharmaceuticals Plc – The most important products
- Exhibit 107: Hikma Pharmaceuticals Plc – Segment focus
- 10.8 Johnson and Johnson
- Exhibit 108 Johnson and Johnson – Overview
- Exhibit No. 109 Johnson and Johnson – Business segments
- Exhibit 110 Johnson and Johnson Johnson The most important information
- Exhibit 111: Johnson and Johnson – Essential products
- Exhibit 112 Johnson and Johnson – – Segment focal
- 10.9 Novartis AG
- Exhibit 113: Novartis AG – Overview
- Exhibit 114: Novartis AG – Business segments
- Exhibits 115 and 115 Novartis AG – Key products
- Exhibit 116: Novartis AG – Segment focus
- 10.10 Pfizer Inc.
- Exhibit 117: Pfizer Inc. – Overview
- Exhibit 118: Pfizer Inc. – Product / Service
- Exhibit 119: Pfizer Inc. – Key news
- Exhibit 120 Pfizer Inc. – Essential products
- 10.11 Teva Pharmaceutical Industries Ltd.
- Exhibit 121: Teva Pharmaceutical Industries Ltd. – Overview
- Exhibit 122: Teva Pharmaceutical Industries Ltd. – Business segments
- Exhibit 123: Teva Pharmaceutical Industries Ltd. – Key news
- Exhibit 124 Teva Pharmaceutical Industries Limited. The key products
- Exhibit 125: Teva Pharmaceutical Industries Ltd. – Segment focus
- 10.12 Viatris Inc.
- Exhibit No. 126 Viatris Inc. – Overview
- Exhibit 127: Viatris Inc. – Business segments
- Exhibit 128 Viatris Inc. – Essential products
- Exhibit 129: Viatris Inc. – Segment focus
11. Appendix
- 11.1 The scope of this report
- 11.2 Checklist of exclusions and inclusions
- Exhibit 130: Inclusions checklist
- Exhibit 131: Exclusions checklist
- 11.3 Rates of currency conversion for US$
- Exhibit 132 Conversion rates of currencies for US$
- 11.4 Research method
- Exhibit 33 Exhibit 133: Research methodology
- Document 134, Validation strategies used for market sizing
- Exhibit 135: Information sources
- 11.5 Abbreviations list
- Exhibit 136: A list of abbreviations
Our Company
Technavio is a global leader in research and advisory firm in the field of technology. Their analysis and research focuses on the latest market trends and offer actionable information to help companies identify potential market opportunities and formulate effective strategies to enhance their competitiveness.
With more than 500 analysts who specialize Technavio’s library of reports consists in more than 17,000 documents and counting, covering more than 800 technologies that span 50 countries. Their client base is comprised of companies of all sizes, comprising more than 100 Fortune 500 companies. The growing client base rely on Technavio’s broad coverage, thorough research and market-based insights that can be used to spot opportunities in the existing as well as potential markets and evaluate their position in changing market dynamics.
ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email:[email protected]Website: www.technavio.com/
SOURCE Technavio
We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.